Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Remimazolam on Postoperative Cough in Patients Undergoing Thyroid Surgery
ChiCTR2500105311Phase 4Not yet recruiting
- Sponsor
- Nanchong City Central Hospital
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in cough (2 arms), sponsored by Nanchong City Central Hospital. Primary endpoint: Incidence of cough. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
cough
Beyond the preview
Go deeper on ChiCTR2500105311.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500105311.